{"id":"https://openalex.org/W4386948810","doi":"https://doi.org/10.1016/j.ygyno.2023.06.468","title":"Mirvetuximab soravtansine (MIRV) in patients with platinum-resistant ovarian cancer with high folate receptor alpha (FR\u03b1) expression: Evaluation of sequence of therapy on anti-tumor activity in the SORAYA study (002)","display_name":"Mirvetuximab soravtansine (MIRV) in patients with platinum-resistant ovarian cancer with high folate receptor alpha (FR\u03b1) expression: Evaluation of sequence of therapy on anti-tumor activity in the SORAYA study (002)","publication_year":2023,"publication_date":"2023-09-01","ids":{"openalex":"https://openalex.org/W4386948810","doi":"https://doi.org/10.1016/j.ygyno.2023.06.468"},"language":"en","primary_location":{"id":"doi:10.1016/j.ygyno.2023.06.468","doi":"https://doi.org/10.1016/j.ygyno.2023.06.468","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ygyno.2023.06.468","pdf_url":"http://www.gynecologiconcology-online.net/article/S0090825823012684/pdf","source":{"id":"https://openalex.org/S2574783","display_name":"Gynecologic Oncology","issn_l":"0090-8258","issn":["0090-8258","1095-6859"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gynecologic Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.gynecologiconcology-online.net/article/S0090825823012684/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009234043","display_name":"Robert Louis Coleman","orcid":"https://orcid.org/0000-0001-9343-8754","observed_orcids":["https://orcid.org/0000-0001-9343-8754"]},"institutions":[{"id":"https://openalex.org/I4210151469","display_name":"The US Oncology Network","ror":"https://ror.org/05xc20j70","country_code":"US","type":"other","lineage":["https://openalex.org/I4210151469"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Coleman","raw_affiliation_strings":["US Oncology Research, The Woodlands, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Oncology Research, The Woodlands, TX, United States","institution_ids":["https://openalex.org/I4210151469"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067053417","display_name":"Ana Oaknin","orcid":"https://orcid.org/0000-0002-3592-7194","observed_orcids":["https://orcid.org/0000-0002-3592-7194"]},"institutions":[{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ana Oaknin","raw_affiliation_strings":["Vall d'Hebron Institute of Oncology, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vall d'Hebron Institute of Oncology, Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083659627","display_name":"Sandro Pignata","orcid":"https://orcid.org/0000-0002-8836-2633","observed_orcids":["https://orcid.org/0000-0002-8836-2633"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Sandro Pignata","raw_affiliation_strings":["Istituto Nazionale Tumori di Napoli Fondazione G Pascale IRCCS, Napoli, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Tumori di Napoli Fondazione G Pascale IRCCS, Napoli, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008683883","display_name":"Hannelore G Denys","orcid":"https://orcid.org/0000-0002-8897-9430","observed_orcids":["https://orcid.org/0000-0002-8897-9430"]},"institutions":[{"id":"https://openalex.org/I2801227569","display_name":"Ghent University Hospital","ror":"https://ror.org/00xmkp704","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801227569"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Hannelore Denys","raw_affiliation_strings":["Ghent University Hospital, Gent, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ghent University Hospital, Gent, Belgium","institution_ids":["https://openalex.org/I2801227569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103127347","display_name":"Nicoletta Colombo","orcid":"https://orcid.org/0000-0003-2225-715X","observed_orcids":["https://orcid.org/0000-0003-2225-715X"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Nicoletta Colombo","raw_affiliation_strings":["European Institute of Oncology IRCCS, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"European Institute of Oncology IRCCS, Milan, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080757346","display_name":"Toon Van Gorp","orcid":"https://orcid.org/0000-0002-2564-721X","observed_orcids":["https://orcid.org/0000-0002-2564-721X","https://orcid.org/0000-0002-1573-8716"]},"institutions":[{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Toon Van Gorp","raw_affiliation_strings":["University Hospital Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I2800231306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005037311","display_name":"Jason A. Konner","orcid":"https://orcid.org/0000-0002-0720-2719","observed_orcids":["https://orcid.org/0000-0002-0720-2719"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason Konner","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY, United States","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011663611","display_name":"Margarita Romeo","orcid":"https://orcid.org/0000-0003-1725-8115","observed_orcids":["https://orcid.org/0000-0003-1725-8115"]},"institutions":[{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]},{"id":"https://openalex.org/I4210153460","display_name":"Hospital Universitari Germans Trias i Pujol","ror":"https://ror.org/04wxdxa47","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210153292","https://openalex.org/I4210153460"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Margarita Romeo Marin","raw_affiliation_strings":["Institut Catal\u00e0 d'Oncologia/Hospital Universitari Germans Trias i Pujol, Badalona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Catal\u00e0 d'Oncologia/Hospital Universitari Germans Trias i Pujol, Badalona, Spain","institution_ids":["https://openalex.org/I4210107147","https://openalex.org/I4210153460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078567055","display_name":"Philipp Harter","orcid":"https://orcid.org/0000-0002-9663-5005","observed_orcids":["https://orcid.org/0000-0002-9663-5005"]},"institutions":[{"id":"https://openalex.org/I4210146447","display_name":"Kliniken Essen-Mitte","ror":"https://ror.org/03v958f45","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210146447"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Philipp Harter","raw_affiliation_strings":["Kliniken Essen-Mitte, Essen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kliniken Essen-Mitte, Essen, Germany","institution_ids":["https://openalex.org/I4210146447"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084340528","display_name":"Conleth G. Murphy","orcid":"https://orcid.org/0000-0002-6923-5911","observed_orcids":["https://orcid.org/0000-0002-6923-5911"]},"institutions":[{"id":"https://openalex.org/I2800693937","display_name":"Bon Secours Hospital Cork","ror":"https://ror.org/0197t7j38","country_code":"IE","type":"healthcare","lineage":["https://openalex.org/I160713005","https://openalex.org/I2800693937"]}],"countries":["IE"],"is_corresponding":false,"raw_author_name":"Conleth Murphy","raw_affiliation_strings":["Bon Secours Hospital Cork and Cancer Trials, Cork, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bon Secours Hospital Cork and Cancer Trials, Cork, Ireland","institution_ids":["https://openalex.org/I2800693937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108612563","display_name":"Brooke Esteves","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096123","display_name":"ImmunoGen (United States)","ror":"https://ror.org/00scb2f23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210096123"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brooke Esteves","raw_affiliation_strings":["ImmunoGen Inc, Waltham, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ImmunoGen Inc, Waltham, MA, United States","institution_ids":["https://openalex.org/I4210096123"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029359855","display_name":"Michael W. Method","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096123","display_name":"ImmunoGen (United States)","ror":"https://ror.org/00scb2f23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210096123"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Method","raw_affiliation_strings":["ImmunoGen Inc, Waltham, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ImmunoGen Inc, Waltham, MA, United States","institution_ids":["https://openalex.org/I4210096123"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061939825","display_name":"Domenica Lorusso","orcid":"https://orcid.org/0000-0003-0981-0598","observed_orcids":["https://orcid.org/0000-0003-0981-0598"]},"institutions":[{"id":"https://openalex.org/I2802557943","display_name":"Agostino Gemelli University Polyclinic","ror":"https://ror.org/00rg70c39","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I2802557943"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Domenica Lorusso","raw_affiliation_strings":["Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy","institution_ids":["https://openalex.org/I2802557943"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058249824","display_name":"Ursula A. Matulonis","orcid":"https://orcid.org/0000-0002-3103-6992","observed_orcids":["https://orcid.org/0000-0002-3103-6992"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ursula Matulonis","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, United States","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":14,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4020,"currency":"USD","value_usd":4020},"apc_paid":null,"fwci":0.4791,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.66651819,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"176","issue":null,"first_page":"S3","last_page":"S3"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mirvetuximab-soravtansine","display_name":"mirvetuximab soravtansine","score":0.9829999804496765},{"id":"https://openalex.org/keywords/platinum-resistant-ovarian-cancer","display_name":"platinum-resistant ovarian cancer","score":0.9539999961853027},{"id":"https://openalex.org/keywords/folate-receptor-alpha","display_name":"folate receptor alpha","score":0.7929999828338623},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9900000095367432},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.8360000252723694},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.48399999737739563},{"id":"https://openalex.org/keywords/treatment-sequencing","display_name":"treatment sequencing","score":0.5289999842643738},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.7440000176429749},{"id":"https://openalex.org/keywords/duration-of-response","display_name":"duration of response","score":0.9340000152587891},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.5559999942779541},{"id":"https://openalex.org/keywords/prior-lines-of-therapy","display_name":"prior lines of therapy","score":0.4819999933242798},{"id":"https://openalex.org/keywords/bevacizumab-resistance","display_name":"bevacizumab resistance","score":0.4399999976158142}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9166699647903442},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7260442972183228},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6160411238670349},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6093752384185791},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.5681614875793457},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5232773423194885},{"id":"https://openalex.org/C2780306303","wikidata":"https://www.wikidata.org/wiki/Q24784504","display_name":"Folate receptor","level":4,"score":0.5209746956825256},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4656568169593811},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4651079773902893},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.42186370491981506},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.4183195233345032},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3910316228866577},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.35299617052078247},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3310386538505554},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.24787220358848572},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2317529320716858},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.12652140855789185},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.ygyno.2023.06.468","doi":"https://doi.org/10.1016/j.ygyno.2023.06.468","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ygyno.2023.06.468","pdf_url":"http://www.gynecologiconcology-online.net/article/S0090825823012684/pdf","source":{"id":"https://openalex.org/S2574783","display_name":"Gynecologic Oncology","issn_l":"0090-8258","issn":["0090-8258","1095-6859"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gynecologic Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.ygyno.2023.06.468","doi":"https://doi.org/10.1016/j.ygyno.2023.06.468","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ygyno.2023.06.468","pdf_url":"http://www.gynecologiconcology-online.net/article/S0090825823012684/pdf","source":{"id":"https://openalex.org/S2574783","display_name":"Gynecologic Oncology","issn_l":"0090-8258","issn":["0090-8258","1095-6859"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gynecologic Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.979200005531311}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4386948810.pdf","grobid_xml":"https://content.openalex.org/works/W4386948810.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4281743548","https://openalex.org/W4295226778","https://openalex.org/W4318580181","https://openalex.org/W4385719183","https://openalex.org/W4312139653","https://openalex.org/W4387135422","https://openalex.org/W4388498222","https://openalex.org/W4399517427","https://openalex.org/W4379662208","https://openalex.org/W4286297240"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2023-09-23T00:00:00"}